New Report: 74% of Medicines in Clinical Development have Potential to be First-in-Class Treatments
A New Report Shows Promise for Patients
What you will find in this free report by The Analysis Group:
  •  As of August 2016, there were more than 6,300 products in clinical development globally
  •  Taking into account that there may be clinical trials underway in more than one indication for a given molecule, these products correspond to over 9,500 projects in clinical development
  •  Development projects were distributed across many therapeutic areas, from cancer to cardiovascular disease and diabetes, to neurology
  •  Approximately three-quarters (74%) of clinical-phase projects were potentially first-in-class
  •  Of the projects in clinical development, 822 were determined to be covered by an orphan drug designation awarded by the FDA
  •  A range of novel scientific approaches to address various diseases and conditions were being pursued in clinical development
Request your copy of the full report here:
    The Biopharmaceutical Pipeline: Innovative Therapies in Clinical Development
    GOBOLDLY (TM) by America's Biopharmaceutical Research Companies
    Copyright 2017 - PhRMA
    Powered By